Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2025-12-28 @ 12:04 AM
Study NCT ID:
NCT06355934
Status:
RECRUITING
Last Update Posted:
2025-12-15
First Post:
2024-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-21
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-12
First Submit QC Date:
None
Study First Post Date:
2024-04-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-12
Last Update Post Date:
2025-12-15
Last Update Post Date Type:
ESTIMATED